A large NHS teaching trust has lost an appeal against a damning employment tribunal judgment that found evidence […]

South Korea has announced it will begin easing social distancing measures from 6 May, as the number of […]

Even a pandemic can’t slow down Seattle Genetics’ new bladder cancer treatment Padcev, which “blew out sales expectations” […]

Researchers in virology and veterinary bacteriology at the University of Bern have cloned the novel coronavirus (SARS-CoV-2). The […]

What is happening to non-covid deaths?In this feature by John Appleby (BMJ 2020;369:m1607, doi:10.1136/bmj.m1607) figure 2 used weekly […]

In this article by Ho and colleagues (BMJ 2020;368, doi:10.1136/bmj.m688, published 18 March 2020) the data for two […]

BCC marks the second non-melanoma skin cancer for which Libtayo has demonstrated first-in-class data, the firms note

The experimental 5-HT1A receptor agonist and D2 receptor antagonist was not effective on primary or secondary endpoints

The move will establish Menarini’s presence in the US biopharma market

The charity’s Centre for Drug Development will sponsor and fund a future Phase I clinical trial for CB213